Company
Founded in September 2019, we are a team of experienced AI/machine learning and business specialists applying state of the art generative AI to drug discovery in close collaboration with biopharmaceutical partners to bring new therapeutics to market across disease areas and positively impact lives.
Our Team
We are a team of experienced AI/machine learning and business specialists applying state of the art generative AI to drug discovery in close collaboration with biopharmaceutical partners to bring new therapeutics to market across disease areas and positively impact lives.
Board, Observers & Outsiders
Funding, Partners & Investors
Founded in September 2019, we are a team of experienced AI/machine learning and business specialists applying state of the art generative AI to drug discovery in close collaboration with biopharmaceutical partners to bring new therapeutics to market across disease areas and positively impact lives.
Press
Variational AI Adds Jennifer Hamilton as Advisor
Variational AI, developer of generative AI-based drug discovery platform for novel kinase inhibitors, today announced that it has added industry and scientific leader Jennifer Hamilton, Ph.D. as a company advisor.
Generative Machine Learning Can Construct Smooth Chemical Search Spaces for Efficient Drug Discovery
The fundamental steps of rational drug design include the identification of a clinically relevant target protein, the discovery of “hit” ligands that weakly modulate the target protein in the desired manner.
Variational AI is hiring!
Please see open job listing below or contact us if you would like to join the team in the area of machine learning, computational medicinal chemistry, and business development.
